Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

  1. Miles, D.W.
  2. Chan, A.
  3. Dirix, L.Y.
  4. Cortés, J.
  5. Pivot, X.
  6. Tomczak, P.
  7. Delozier, T.
  8. Sohn, J.H.
  9. Provencher, L.
  10. Puglisi, F.
  11. Harbeck, N.
  12. Steger, G.G.
  13. Schneeweiss, A.
  14. Wardley, A.M.
  15. Chlistalla, A.
  16. Romieu, G.
Revista:
Journal of Clinical Oncology

ISSN: 0732-183X 1527-7755

Ano de publicación: 2010

Volume: 28

Número: 20

Páxinas: 3239-3247

Tipo: Artigo

DOI: 10.1200/JCO.2008.21.6457 GOOGLE SCHOLAR